|
KIAA0892 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.227300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.283000E-03 |
| Normal-vs-Stage2 |
5.982900E-03 |
| Normal-vs-Stage3 |
3.93859999999746E-05 |
| Normal-vs-Stage4 |
1.087910E-02 |
| Stage1-vs-Stage2 |
3.827800E-01 |
| Stage1-vs-Stage3 |
2.748000E-02 |
| Stage1-vs-Stage4 |
5.392600E-01 |
| Stage2-vs-Stage3 |
5.152600E-01 |
| Stage2-vs-Stage4 |
8.475800E-01 |
| Stage3-vs-Stage4 |
3.671000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.161400E-04 |
| Normal-vs-AfricanAmerican |
9.655800E-02 |
| Normal-vs-Asian |
4.813800E-01 |
| Caucasian-vs-AfricanAmerican |
5.621200E-01 |
| Caucasian-vs-Asian |
1.578340E-02 |
| AfricanAmerican-vs-Asian |
2.820200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.464500E-03 |
| Normal-vs-Female |
6.004400E-04 |
| Male-vs-Female |
8.811800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.103540E-02 |
| Normal-vs-Age(41-60Yrs) |
1.224880E-03 |
| Normal-vs-Age(61-80Yrs) |
2.192900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.632190E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.966790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.733500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.509810E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.424000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.835600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.675400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.249700E-04 |
| Classical-VS-Follicular |
9.565800E-04 |
| Classical-VS-Other |
9.147800E-01 |
| Classical-VS-Normal |
2.137700E-02 |
| Tall-VS-Follicular |
3.436400E-01 |
| Tall-VS-Other |
7.319700E-02 |
| Tall-VS-Normal |
1.86594000000095E-05 |
| Follicular-VS-Other |
2.482000E-01 |
| Follicular-VS-Normal |
2.48909999999158E-05 |
| Other-VS-Normal |
4.205600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.244850E-03 |
| Normal-vs-N1 |
1.190120E-02 |
| N0-vs-N1 |
9.481800E-01 |
|
|
